Cytisinicline

We, like you, are gaining clinical experience and expertise in helping our clients to quit using cytisinicline. As we learn more, we will develop more training and support materials for you.

This section hosts a number of resources, including a short film, a briefing, a summary and dosing guide, a template PGD and information for a Medicines Management application to add cytisinicline to your formulary.

NEW! The cytisinicline section of our online Stop smoking aids module now includes modelling film clips giving examples of how to discuss cytisinicline with clients and on dealing with questions that they may have. The film clips were part-funded by a grant provided by Consilient Health who had no influence or input into the content.

Cytisinicline

Cytisinicline (also known as cytisine) is now a licensed prescription-only medication in the UK.

This short film summarises what cytisinicline offers and urges health and social care organisations to make it available to people who smoke. The film was part-funded by a grant provided by Consilient Health who had no influence or input into the content.

Consilient Health announced the availability of Cytisine (now known as Cytisinicline) in January 2024 and Viatris launched Belnifrem® in June 2025.

A recent update from NICE, which incorporates cytisinicline into their smoking cessation guidelines [NG209], is available here.

The following resources can be found at the end of this page:

Cytisinicline briefing
Cytisinicline summary and dosing guide
Cytisinicline Summary of Product Characteristics (SPC)
Cytisinicline application: Our colleagues from Greater Manchester have made an application to their Medicines Management Board to get cytisinicline on their ICB formulary; they have kindly allowed us to include it here as a resource
Belnifrem overview

We will continue to develop resources as we gain more experience and expertise in the use of cytisinicline.

Cytisinicline briefing

Cytisinicline summary and dosing guide

Cytisinicline Summary of Product Characteristics

GMMMG Cytisinicline application

Belnifrem overview

Cytisinicline Patient Group Direction (PGD)

The NHS Specialist Pharmacy Services (SPS) has developed a Patient Group Direction (PGD) as a template for you to develop your own local PGD.

This link will take you to the Specialist Pharmacy Services PGD page so that, if the PGD is ever updated, you will have the most up to date version: Cytisinicline for smoking cessation – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice